Keeping Participants in the Study

Part of Clinical Research Coordinator (CRC) Training: Recruitment, Screening and Enrollment.

About 5 minutes. Free, in your language, no account needed.

Why this matters

Every participant who leaves takes their data with them. A study sized for 400 people that loses 120 may no longer be able to answer its question, and the people who left are rarely a random sample of those who stayed.

Retention is also the clearest measure of whether a site treats people well. Sites with good retention are almost always sites where somebody answers the phone.

Why people leave

Understand the reasons before designing the fixes.

• Burden. Visits are long, frequent, or badly timed. Travel and parking cost money. Time off work costs more.
• Side effects, or the fear of them.
• Feeling like a subject rather than a person. No continuity of staff, no explanation, no follow-up after a difficult visit.
• Life events. Moving, a new job, caring responsibilities, unrelated illness.
• Loss of belief. They no longer think the study will help anyone, often because nobody has told them how it is going.
• A single bad experience. A rude reception, a two-hour wait, a lost blood sample requiring a repeat.

Only some of these are inside your control. Enough of them are.

What works

Set expectations honestly at consent. The largest single cause of early withdrawal is a participant discovering the study is more demanding than they understood. Say the real number of visits, the real duration, and the real procedures, including the unpleasant ones. People who join with accurate expectations stay.

Reduce burden wherever the protocol allows.

• Schedule around the participant's life, not the clinic's convenience.
• Combine study visits with routine appointments where permitted.
• Pay travel and time promptly at the approved rate. A reimbursement that arrives four months late is a reason to leave.
• Keep waiting times short and tell people how long a visit will actually take.

Provide continuity. Where possible, the same coordinator sees the same participants. Where that is impossible, make sure whoever they meet has read the notes and knows their name.

Communicate between visits. A reminder a few days before each visit, sent the way that person prefers. A short call after a visit where something difficult happened. Study newsletters where the sponsor provides approved material.

Notice early. A missed call, a late arrival, a shorter answer than usual. Contact people after one missed visit, not after three.

Where the limits are

Retention has ethical boundaries, and crossing them is a serious matter.

• Withdrawal is an absolute right. A participant may stop at any time, without giving a reason, and without any effect on their ordinary care. You may ask, once and gently, whether something can be changed to make continuing possible. You may not press.
• Payment may not be structured to trap people. A payment held back until the final visit, of a size that makes leaving costly, is coercive.
• Do not use the relationship as leverage. "After everything we have done for you" is not a retention strategy.
• All retention material needs approval, in the same way as recruitment material.

Withdrawal is not one thing

This distinction saves data that is otherwise lost.

• A participant may stop study treatment but agree to continue attending for assessments.
• They may stop attending visits but agree to follow-up by telephone.
• They may withdraw from the study entirely but permit the data already collected to be kept and used.
• They may, in some jurisdictions and depending on their consent, request that no further data be collected at all.

Ask which one they mean, in that order, and record the answer precisely. Most people who say "I want to stop" mean the first.

When someone does leave

• Record the date and the reason as they gave it, not as you interpreted it.
• Complete any early termination visit and safety follow-up the protocol requires.
• Make sure their ongoing clinical care is handed back properly.
• Thank them. They gave you something.
• Look for patterns across withdrawals. Three people leaving for the same reason is information about your site.

In practice

VT-201 at Northside Clinic is losing participants around month four. Nadia calls the last six people who left and asks what happened.

Five say the same thing, in different words. The month-four visit takes most of a day, requires fasting, and is booked in the afternoon. They arrive hungry, wait, and decide it is not worth it.

Two changes follow. Fasting visits move to the first appointment of the morning, and participants are told at consent that this one visit is long, so it is no longer a surprise. Nadia also starts calling each participant three days before the month-four visit.

Retention at month four rises over the next two quarters. Nadia has changed nothing about the protocol; she has changed the appointment time and the honesty of the briefing.

One participant still leaves, because her mother becomes ill and she has no time. Nadia records the reason, completes the safety follow-up, asks whether her existing data may be kept, and thanks her. That is a good outcome too.

Key takeaways

• Dropout is a scientific problem, because a study can become underpowered and because the people who leave are rarely a random sample of those who joined.
• Honest expectation-setting at consent is the strongest retention tool, since most early withdrawals come from a study being more demanding than a participant understood.
• Withdrawal is an absolute right, exercisable at any time without reason and without effect on ordinary care, and retention efforts must never become pressure.
• Withdrawal has degrees — stopping treatment, stopping visits, stopping all data collection — and asking precisely which one a participant means preserves data they are willing to give.
• Patterns in withdrawal reasons are information about the site, and are often fixed by scheduling and communication rather than by protocol change.